Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

IMPORTANCE: To date, extended-release naltrexone hydrochloride has not previously been compared directly with opioid medication treatment (OMT), currently the most commonly prescribed treatment for opioid dependence. OBJECTIVE: To determine whether treatment with extended-release naltrexone will be...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Psychiatry
Auteurs principaux: Tanum, Lars, Solli, Kristin Klemmetsby, Latif, Zill-e-Huma, Benth, Jūratė Šaltytė, Opheim, Arild, Sharma-Haase, Kamni, Krajci, Peter, Kunøe, Nikolaj
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2017
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583381/
https://ncbi.nlm.nih.gov/pubmed/29049469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2017.3206
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires